Word

XCOPRI

Status

Registered

Status Code

700

Status Date

Tuesday, July 28, 2020

Serial Number

88485671

Registration Number

6110858

Registration Date

Tuesday, July 28, 2020

Mark Type

3000

Filing Date

Monday, June 24, 2019

Published for Opposition

Tuesday, May 12, 2020

Trademark Owner History

SK BIOPHARMACEUTICALS CO., LTD. - Original Registrant

Classifications

5 Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; sanitary preparations for medical use; biological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; ferments for pharmaceutical purposes; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for sanitary use; pharmaceutical preparations for immunity adjustment; vitamin preparations; vaccines; dietary supplements; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases; bacteriological preparations for medical and veterinary use; blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets

The colors purple and red are claimed as a feature of the mark.
The mark consists of the stylized word "XCOPRI" in purple upper case letters. The backwards slash in the letter "X" is formed by a red triangular design. The remaining color white represents background and is not a feature of the mark.

Trademark Events

Jul 28, 2020

Registered-Principal Register

May 12, 2020

Official Gazette Publication Confirmation E-Mailed

May 12, 2020

Published For Opposition

Apr 22, 2020

Notification Of Notice Of Publication E-Mailed

Apr 7, 2020

Approved For Pub - Principal Register

Mar 24, 2020

Teas/Email Correspondence Entered

Mar 24, 2020

Correspondence Received In Law Office

Mar 23, 2020

Assigned To Lie

Mar 16, 2020

Teas Response To Suspension Inquiry Received

Oct 7, 2019

Assigned To Examiner

Sep 16, 2019

Notification Of Letter Of Suspension E-Mailed

Sep 16, 2019

Letter Of Suspension E-Mailed

Sep 16, 2019

Suspension Letter Written

Sep 12, 2019

Assigned To Examiner

Jul 3, 2019

Notice Of Design Search Code E-Mailed

Jul 2, 2019

New Application Office Supplied Data Entered In Tram

Jun 27, 2019

New Application Entered In Tram